rs146027947
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001081.4(CUBN):c.10039G>A(p.Gly3347Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00228 in 1,613,966 control chromosomes in the GnomAD database, including 47 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001081.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CUBN | NM_001081.4 | c.10039G>A | p.Gly3347Arg | missense_variant | 63/67 | ENST00000377833.10 | |
CUBN | XM_011519709.3 | c.6025G>A | p.Gly2009Arg | missense_variant | 37/41 | ||
CUBN | XM_011519710.3 | c.6001G>A | p.Gly2001Arg | missense_variant | 37/41 | ||
CUBN | XM_011519711.4 | c.5881G>A | p.Gly1961Arg | missense_variant | 36/40 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CUBN | ENST00000377833.10 | c.10039G>A | p.Gly3347Arg | missense_variant | 63/67 | 1 | NM_001081.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00777 AC: 1182AN: 152168Hom.: 16 Cov.: 32
GnomAD3 exomes AF: 0.00507 AC: 1272AN: 250972Hom.: 20 AF XY: 0.00424 AC XY: 576AN XY: 135746
GnomAD4 exome AF: 0.00171 AC: 2497AN: 1461680Hom.: 31 Cov.: 31 AF XY: 0.00160 AC XY: 1166AN XY: 727166
GnomAD4 genome AF: 0.00777 AC: 1183AN: 152286Hom.: 16 Cov.: 32 AF XY: 0.00772 AC XY: 575AN XY: 74452
ClinVar
Submissions by phenotype
Imerslund-Grasbeck syndrome type 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Imerslund-Grasbeck syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at